Welcome to a new world of CT simulation

Welcome to a new world of CT simulation
Welcome to a new world of CT simulation
 
Contact Us

Modern radiotherapy planning demands images that provide reliable information about the tumor and surrounding organs. Yet for years now, the process involved in acquiring this information has been time-consuming and prone to errors. A leap forward in CT simulation is long overdue.

But now things are changing.

We are introducing two brand-new solutions that redefine what a CT simulator should be

We’ve transformed CT technology to create meaningful, large-bore RT imaging solutions that unlock key innovations for your field. And by integrating dedicated RT hardware and AI-supported software, they come ready-equipped to enable you to fight cancer on a new level.

Our new solutions for CT simulation transform care delivery. Every single step is truly tailored to helping you achieve the ideal starting point for optimal RT planning and better outcomes.

SOMATOM go.Sim and go.Open Pro are pending 510(k) clearance, and are not yet commercially available in the United States.

Staying competitive in a growing market

Today’s healthcare providers are under increasing pressure to deliver RT to more patients than ever before. This demands innovative solutions that will allow you to work more efficiently and lay the foundations for the best possible treatments and optimal patient outcomes.


A global disease

Cancer is universal. It is the second leading cause of death worldwide and was responsible for 17% of all lives lost in 2017.1 The world’s population is also getting older, with the number of over-60s set to increase significantly between now and 2050.2

A growing problem

With cancer cases expected to surge between now and 2030,3 RT departments will have to treat more patients than ever. Tumors in areas with respiratory motion will be a major obstacle in many of these cases.


An imperfect workflow

The rise in RT patients will add further pressure to the already complex and challenging RT workflow. Patients often go through the five-step process multiple times.

A fundamental starting point for treatment is CT simulation that consistently delivers high-quality information about the tumor and surrounding organs. Yet a lack of integration, automization, and standardization means that workflows are often time-consuming, highly prone to error, and dependent on individual experience and the patient’s ability to follow instructions.

Our new CT simulators

At Siemens Healthineers, treatment preparation is our area of expertise. That’s why we want to optimize this part of the process by addressing the lack of integration in existing systems.

Everything is truly tailored to helping you achieve the ideal starting point for optimal RT planning and better outcomes.

Powered by co-creation

To explore what really matters to you, we asked over 300 RT specialists – radiation oncologists, medical physicists, dosimetrists, RTTs, and financial decision makers – to give us insights into your world.

Powered by artificial intelligence

Our new solutions enable precise organ-at-risk contouring thanks to AI-powered patient modeling. They automate and standardize key CT simulation steps, and directly deliver high-quality TPS-ready data.

SOMATOM go.Sim and go.Open Pro are pending 510(k) clearance, and are not yet commercially available in the United States.

SOMATOM go.Sim and go.Open Pro are pending 510(k) clearance, and are not yet commercially available in the United States.

1World Health Organisation, 2018: https://www.who.int/news-room/fact-sheets/detail/cancer.

2World Health Organisation, 2018: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health.

3Union for International Cancer Control (UICCI), https://www.uicc.org; Cancer Research UK, www.cancerresearchuk.org.

4RTAnswers.com, www.rtanswers.org/treatment information/cancertypes/headneck/index.aspx, accessed May 11, 2015.

5International Agency for Research on Cancer, https://www.iarc.fr.

6Source (3): Union for International Cancer Control (UICCI), https://www.uicc.org; Cancer Research UK, www.cancerresearchuk.org.
Source (4): RTAnswers.com, www.rtanswers.org/treatmentinformation/cancertypes/headneck/index.aspx, accessed May 11, 2015.